| Application no. and date | 17785013.8 (espacenet) (Federated) (European Patent Register), 20170922 | | Patent/reg. no. and date | DK/EP 3515937, 20251217 | | Publication date | 20190731 | | Priority no. and date | US 201662399180 P, 20160923, US 201762558557 P, 20170914 | | EP pub. no. and date |
EP 3515937 20190731 | | Effective date | | | Applicant/owner | Teva Pharmaceuticals International GmbH, Schlüsselstrasse 12
8645 Rapperswil-Jona, CH | | Applicant ref. no. | V501279DK00 | | Inventor | BIGAL, Marcelo, 4269 Arbor Lane
Doylestown
Pennsylvania 18902, US,
AYCARDI, Ernesto, 1 Deerberry Lane
Andover
Massachusetts 10810, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61P 25/06 (2006.01) , C07K 16/18 (2006.01) | | Title | BEHANDLING AF REFRAKTORISK MIGRÆNE | | Int. application no. | IB2017055777 | | Int. publication no. | WO2018055574 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
